China NMPA Product Recall - Trauma Surgical Instrument Kit

On July 11, 2016, the National Medical Products Administration (NMPA) published a recall notice regarding trauma surgical instrument kits manufactured by Synthes GmbH and distributed by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. The recall, initiated voluntarily by Synthes GmbH, stemmed from biosafety assessment failures. Under specific experimental conditions, the products demonstrated cytotoxicity issues, marked by high growth inhibition levels, potentially due to corrosion at the instruments' weld points. Such corrosion during surgical use could expose patients to cytotoxic substances, leading to adverse tissue reactions and surgical delays. This action falls under the NMPA's regulatory oversight for medical device safety.

Synthes GmbH confirmed that the specific affected product batches were not imported or sold in China. Consequently, Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. reported that no direct corrective actions were required within China for these particular units. However, the NMPA requested that provincial, autonomous region, and municipal food and drug administration bureaus enhance their supervision and management of similar medical devices to safeguard public health. The initial report detailing these findings was submitted by Johnson & Johnson Medical (China) Ltd. on May 26, 2016.